Frankel, A. E., Coughlin, L. A., Kim, J., Froehlich, T. W., Xie, Y., Frenkel, E. P., & Koh, A. Y. (2017). Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia (New York, N.Y.), 19(10), 848-855. https://doi.org/10.1016/j.neo.2017.08.004
Chicago-Zitierstil (17. Ausg.)Frankel, Arthur E., Laura A. Coughlin, Jiwoong Kim, Thomas W. Froehlich, Yang Xie, Eugene P. Frenkel, und Andrew Y. Koh. "Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients." Neoplasia (New York, N.Y.) 19, no. 10 (2017): 848-855. https://doi.org/10.1016/j.neo.2017.08.004.
MLA-Zitierstil (9. Ausg.)Frankel, Arthur E., et al. "Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients." Neoplasia (New York, N.Y.), vol. 19, no. 10, 2017, pp. 848-855, https://doi.org/10.1016/j.neo.2017.08.004.